Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer
Open Access
- 17 January 2024
- journal article
- review article
- Published by Elsevier in Journal of Advanced Research
- Vol. 67, 231-252
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (21S21900900, 22S21902700)
- National Natural Science Foundation of China (82073385, 82172706)
This publication has 214 references indexed in Scilit:
- Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrinOncogene, 2013
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppressionSeminars in Cancer Biology, 2012
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lungThe Journal of Thoracic and Cardiovascular Surgery, 2010
- The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell CarcinomaCancer Research, 2010
- Differentiation of Effector CD4 T Cell PopulationsAnnual Review of Immunology, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- Cancer-related inflammationNature, 2008
- Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approachBritish Journal of Cancer, 2006
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004